They write because BPC-157 has not been extensively studied in humans, no one knows if there is a safe dose, or if there is any way to use this compound safely to treat specific medical conditions. Furthermore, USADA highlights that BPC 157 is not approved for human use as a drug, and there's a notable lack of published clinical trial data
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures
Possible effects and mechanisms of dietary natural products and nutrients on depression and anxiety: a narrative review
Eight weeks post-vaccination, a decrease in number and size of atherosclerotic plaques was reported, along with a decrease of GPNMB senescent cells number
For Lebers optic atrophy or smokers blindness, the usual dose starts at 1000mcg, given daily for 2 weeks, followed by twice weekly